Recently TASK investigator Dr Caryn Upton traveled to Dallas, Texas in the United States to attend the annual American Thoracic Society conference to present a poster on a case report. The case presented was regarding a patient enrolled on a clinical trial with asymptomatic TB in the brain who appears to have been successfully treated with the NIX TB regimen of bedaquiline, pretomanid and linezolid.
Quote “I am specifically interested in this case because research on TB meningitis and drug penetration into the brain is severely lacking. This case represents an important first step in investigating the role of novel agents in this devastating disease.”
Dr Upton is an investigator on several clinical trials at TASK, specifically deployed at TASK Brooklyn where the focus is on MDR and XDR research.